Literature DB >> 14202754

PLASMA INSULIN IN ORGANIC HYPERINSULINISM: COMPARATIVE EFFECTS OF TOLBUTAMIDE, LEUCINE AND GLUCOSE.

J C FLOYD, S S FAJANS, R F KNOPF, J W CONN.   

Abstract

Entities:  

Keywords:  BLOOD; BLOOD CHEMICAL ANALYSIS; BLOOD SUGAR; GLUCAGON; GLUCOSE; HYPERGLYCEMIA; HYPERINSULINISM; HYPOGLYCEMIA; INSULIN; ISLET CELL TUMOR; LEUCINE; PHARMACOLOGY; SURGERY, OPERATIVE; TOLBUTAMIDE

Mesh：

Substances：

Year:  1964        PMID： 14202754     DOI： 10.1210/jcem-24-8-747

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  22 in total

1.  TOLBUTAMIDE TEST: A MISLEADING RESPONSE.

Authors:  H C FORD; R E BAILEY
Journal:  Br Med J       Date:  1965-08-07

Review 2.  Food intolerance in humans.

Authors:  R H Herman; L Hagler
Journal:  West J Med       Date:  1979-02

3.  Current surgical management of functioning islet cell tumors of the pancreas.

Authors:  T S Harrison; C G Child; W J Fry; J C Floyd; S S Fajans
Journal:  Ann Surg       Date:  1973-10       Impact factor: 12.969

4.  Clinical use of radioimmunological plasma insulin assessment.

Authors:  J P Felber
Journal:  Klin Wochenschr       Date:  1973-01-15

5.  Pancreatic islet beta cell tumors and hyperplasia: experience in 14 Seattle hospitals.

Authors:  H Kavlie; T T White
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

Review 6.  Progress report. Diagnosis of insulinoma.

Authors:  V Marks
Journal:  Gut       Date:  1971-10       Impact factor: 23.059

7.  Insulinoma in childhood.

Authors:  J R Mann; P H Rayner; A Gourevitch
Journal:  Arch Dis Child       Date:  1969-08       Impact factor: 3.791

8.  Islet cell tumors and hypoglycemia.

Authors:  C Williams; G H Bryson; D M Hume
Journal:  Ann Surg       Date:  1969-05       Impact factor: 12.969

9.  Sulfonylurea-induced factitious hypoglycemia in a nondiabetic nurse.

Authors:  P G Walfish; R P Kashyap; S Greenstein
Journal:  Can Med Assoc J       Date:  1975-01-11       Impact factor: 8.262

10.  Portal, hepatic and peripheral insulin immunoreactive substances before and after removal of an insulinoma.

Authors:  C Villaume; B Beck; J P Pointel; P Drouin; G Debry
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.